Centro de Investigación de Medicina Aplicada (CIMA)
Centro / Instituto vinculado a la Universidad de Navarra
University of Cologne
Colonia, AlemaniaPublicaciones en colaboración con investigadores/as de University of Cologne (12)
2024
-
AI is a viable alternative to high throughput screening: a 318-target study
Scientific Reports, Vol. 14, Núm. 1
-
Astrocytic GLUT1 reduction paradoxically improves central and peripheral glucose homeostasis
Science Advances , Vol. 10, Núm. 42
-
Correction to: AI is a viable alternative to high throughput screening: a 318-target study (Scientific Reports, (2024), 14, 1, (7526), 10.1038/s41598-024-54655-z)
Scientific Reports
2021
-
Subcellular distribution of p53 by the p53-Responsive lncRNA NBAT1 Determines Chemotherapeutic Response in Neuroblastoma
Cancer Research, Vol. 81, Núm. 6, pp. 1457-1471
2020
-
Clinical significance of TP53, BIRC3, ATM and MAPK-ERK genes in chronic lymphocytic leukaemia: data from the randomised UK LRF CLL4 trial
Leukemia, Vol. 34, Núm. 7, pp. 1760-1774
-
RIPK1 Mediates TNF-Induced Intestinal Crypt Apoptosis During Chronic NF-κB Activation
Cellular and Molecular Gastroenterology and Hepatology, Vol. 9, Núm. 2, pp. 295-312
2019
-
Clinical significance of DNA methylation in chronic lymphocytic leukemia patients: Results from 3 UK clinical trials
Blood Advances, Vol. 3, Núm. 16, pp. 2474-2481
2018
-
Sense-Antisense lncRNA Pair Encoded by Locus 6p22.3 Determines Neuroblastoma Susceptibility via the USP36-CHD7-SOX9 Regulatory Axis
Cancer Cell, Vol. 33, Núm. 3, pp. 417-434.e7
2015
-
Neuregulin-1β induces mature ventricular cardiac differentiation from induced pluripotent stem cells contributing to cardiac tissue repair
Stem Cells and Development, Vol. 24, Núm. 4, pp. 484-496
2008
-
Lethality in an anti-angiogenic tumor gene therapy model upon constitutive but not inducible expression of the soluble vascular endothelial growth factor receptor 1
Journal of Gene Medicine, Vol. 10, Núm. 10, pp. 1083-1091
2004
-
Prolonged and Inducible Transgene Expression in the Liver Using Gutless Adenovirus: A Potential Therapy for Liver Cancer
Gastroenterology, Vol. 126, Núm. 1 SUPPL. 1, pp. 278-289